CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | MARIANI PETER J Chief Financial Officer | Grant or award | +3,157 | 19,023 | ||
| 2021-02-16 | Zaderej Karen L. CEO | Grant or award | +16,021 | 625,120 | ||
| 2021-02-16 | Zaderej Karen L. CEO | Grant or award | +13,978 | 634,916 | ||
| 2021-02-16 | Billet Isabelle Chief Strategy and BD Officer | Grant or award | +1,325 | 11,534 | ||
| 2021-02-05 | Donovan Michael Patrick VP Operations | Option exercise | +20,000 | $5.14 | $103K | 46,029 |
| 2021-02-05 | Donovan Michael Patrick VP Operations | Shares withheld for taxes | −5,190 | $19.81 | $103K | 40,839 |
| 2021-02-05 | Donovan Michael Patrick VP Operations | Option exercise · Employee Stock Option (right to purchase) | −20,000 | 0 | ||
| 2021-01-08 | Zaderej Karen L. CEO | Sale | −65,000 | $20.00 | $1.3M | 609,099 |
| 2020-12-30 | Donovan Michael Patrick VP Operations | Sale | −1,733 | $17.48 | $30K | 26,029 |
| 2020-12-29 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Sale | −371 | $17.81 | $7K | 63,240 |
| 2020-12-29 | Donovan Michael Patrick VP Operations | Sale | −567 | $17.81 | $10K | 27,762 |
| 2020-12-29 | Freitag Gregory Gene Director | Sale | −916 | $17.81 | $16K | 248,345 |
| 2020-12-29 | MARIANI PETER J Chief Financial Officer | Sale | −1,293 | $17.81 | $23K | 10,376 |
| 2020-12-29 | Scopelianos Angelo VP Research & Development | Sale | −567 | $17.81 | $10K | 5,529 |
| 2020-12-29 | Zaderej Karen L. CEO | Sale | −3,500 | $17.81 | $62K | 674,099 |
| 2020-12-29 | Friedman Mark Louis VP,Regulatory & Quality | Sale | −567 | $17.81 | $10K | 11,124 |
| 2020-12-29 | MARTINEZ MARIA D. Chief Human Resources Officer | Sale | −567 | $17.81 | $10K | 4,665 |
| 2020-12-29 | Billet Isabelle Chief Strategy and BD Officer | Sale | −649 | $17.81 | $12K | 9,496 |
| 2020-12-27 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Grant or award | +1,500 | 63,611 | ||
| 2020-12-27 | Donovan Michael Patrick VP Operations | Grant or award | +2,300 | 28,329 |
Page 39 of 69 · 1,376 trades